[Observational studies to evaluate the clinical effectiveness of drugs. Use of guide lists for their design, analysis, and interpretation].
Soto Alvarez
J
J
Departamento de Farmacoepidemiología-Farmacoeconomía, Unidad Médica, Pfizer, S.A., Spain. javier.soto.alvarez@pfizer.com
D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards*; D003627:Data Interpretation, Statistical; D004358:Drug Therapy; D006801:Humans; D011446:Prospective Studies; D012189:Retrospective Studies; D011795:Surveys and Questionnaires
Stat Med. 1991 Apr;10(4):577-81
2057656
Value Health. 2003 Mar-Apr;6(2):90-7
12641858
Aten Primaria. 1998 Jul-Aug;22(3):182-5
9741173
Ann Pharmacother. 1992 Jan;26(1):96-8
1535003
Drug Saf. 1991 Sep-Oct;6(5):381-9
1930744
Med Clin (Barc). 1998 Sep 12;111(7):267-76
9789243
N Engl J Med. 2000 Jun 22;342(25):1878-86
10861324
N Engl J Med. 1993 Dec 30;329(27):2029-32
8018139
Am J Ther. 2002 May-Jun;9(3):199-205
11941379
Med Clin (Barc). 1999 Jul 3;113(4):156-7
10472603
Clin Pharmacol Ther. 1983 Jul;34(1):1-7
6861430
N Engl J Med. 2000 Jun 22;342(25):1907-9
10861329
BMJ. 1996 May 11;312(7040):1215-8
8634569
Pharmacoepidemiol Drug Saf. 1997 Oct;6 Suppl 3:S51-9
15073755
Ann Intern Med. 1997 Oct 15;127(8 Pt 2):666-74
9382378